Hipertension y Riesgo Vascular最新文献

英文中文

Hypertension and uric acid, uric acid and hypertension: Is hyperuricaemia a new vascular risk factor to take into account? 高血压与尿酸，尿酸与高血压：高尿酸血症是需要考虑的新血管风险因素吗？

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-29 DOI: 10.1016/j.hipert.2024.12.001

M Benitez Camps

引用次数: 0

Refractory arterial hypertension. What can we offer these patients? 难治性动脉高血压。我们能为这些病人提供什么？

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-20 DOI: 10.1016/j.hipert.2024.12.004

J Segura, P Armario

引用次数: 0

Diseño y racional estudio observacional del Grupo Argentino Estudio Lipoproteína (a) [设计与原理：阿根廷脂蛋白（a）研究小组的观察性研究]。

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-01 DOI: 10.1016/j.hipert.2024.07.005

P. Corral , A. Lavalle Cobo , M.F. Arrupe , L. Schreier , G. Matta , N.F. Renna , en nombre de los investigadores de GAELp(a)

Introduction

Elevated levels of Lipoprotein(a) [Lp(a)] have been linked to increased cardiovascular risk globally. However, comprehensive studies on Lp(a) levels and their impact on cardiovascular health in Argentina are lacking. The Argentine Group for the Study of Lipoprotein (a) [GAELp(a)] aims to address this gap through an observational study designed to evaluate the prevalence and consequences of elevated Lp(a) levels in the Argentine population.

Methods

The GAELp(a) study will recruit participants from diverse regions across Argentina. Eligible individuals will undergo comprehensive assessments, including demographic data collection, medical history review, and laboratory analyses to measure Lp(a) levels. The study will employ rigorous statistical analyses to explore the association between elevated Lp(a) levels and cardiovascular outcomes, considering potential confounding variables.

Results

Anticipated outcomes of the GAELp(a) study include a detailed characterization of Lp(a) levels within the Argentine population and their correlation with cardiovascular diseases. By elucidating these relationships, the study aims to provide valuable insights into the prevalence and impact of elevated Lp(a) on cardiovascular health in Argentina.

Conclusion

The GAELp(a) observational study holds promise for enhancing our understanding of Lp(a)-related cardiovascular risk in Argentina. Findings from this study may contribute to the development of targeted interventions, clinical guidelines, and public health policies aimed at reducing cardiovascular morbidity and mortality associated with elevated Lp(a) levels. Through collaborative efforts, the GAELp(a) study seeks to advance cardiovascular research and improve healthcare outcomes in Argentina.

导言：在全球范围内，脂蛋白（a）[Lp（a）]水平升高与心血管风险增加有关。然而，阿根廷缺乏有关脂蛋白（a）水平及其对心血管健康影响的全面研究。阿根廷脂蛋白（a）研究小组[GAELp(a)]旨在通过一项观察性研究，评估阿根廷人口中脂蛋白（a）水平升高的患病率和后果，从而填补这一空白：GAELp(a) 研究将从阿根廷不同地区招募参与者。符合条件的人员将接受全面评估，包括人口统计学数据收集、病史审查和测量脂蛋白（a）水平的实验室分析。考虑到潜在的混杂变量，该研究将采用严格的统计分析来探讨脂蛋白（a）水平升高与心血管结果之间的关联：GAELp（a）研究的预期成果包括详细描述阿根廷人口的脂蛋白（a）水平及其与心血管疾病的相关性。通过阐明这些关系，该研究旨在为了解脂蛋白（a）升高在阿根廷的流行情况及其对心血管健康的影响提供有价值的见解：GAELp（a）观察性研究有望加深我们对阿根廷与脂蛋白（a）相关的心血管风险的了解。这项研究的结果可能有助于制定有针对性的干预措施、临床指南和公共卫生政策，以降低与脂蛋白（a）水平升高相关的心血管疾病发病率和死亡率。通过共同努力，GAELp（a）研究旨在推动阿根廷的心血管研究并改善医疗保健成果。

{"title":"Diseño y racional estudio observacional del Grupo Argentino Estudio Lipoproteína (a)","authors":"P. Corral , A. Lavalle Cobo , M.F. Arrupe , L. Schreier , G. Matta , N.F. Renna , en nombre de los investigadores de GAELp(a)","doi":"10.1016/j.hipert.2024.07.005","DOIUrl":"10.1016/j.hipert.2024.07.005","url":null,"abstract":"<div><h3>Introduction</h3><div>Elevated levels of Lipoprotein(a) [Lp(a)] have been linked to increased cardiovascular risk globally. However, comprehensive studies on Lp(a) levels and their impact on cardiovascular health in Argentina are lacking. The Argentine Group for the Study of Lipoprotein (a) [GAELp(a)] aims to address this gap through an observational study designed to evaluate the prevalence and consequences of elevated Lp(a) levels in the Argentine population.</div></div><div><h3>Methods</h3><div>The GAELp(a) study will recruit participants from diverse regions across Argentina. Eligible individuals will undergo comprehensive assessments, including demographic data collection, medical history review, and laboratory analyses to measure Lp(a) levels. The study will employ rigorous statistical analyses to explore the association between elevated Lp(a) levels and cardiovascular outcomes, considering potential confounding variables.</div></div><div><h3>Results</h3><div>Anticipated outcomes of the GAELp(a) study include a detailed characterization of Lp(a) levels within the Argentine population and their correlation with cardiovascular diseases. By elucidating these relationships, the study aims to provide valuable insights into the prevalence and impact of elevated Lp(a) on cardiovascular health in Argentina.</div></div><div><h3>Conclusion</h3><div>The GAELp(a) observational study holds promise for enhancing our understanding of Lp(a)-related cardiovascular risk in Argentina. Findings from this study may contribute to the development of targeted interventions, clinical guidelines, and public health policies aimed at reducing cardiovascular morbidity and mortality associated with elevated Lp(a) levels. Through collaborative efforts, the GAELp(a) study seeks to advance cardiovascular research and improve healthcare outcomes in Argentina.</div></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"42 1","pages":"Pages 13-17"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Update on the diagnosis of the pheochromocytoma 嗜铬细胞瘤诊断的最新进展。

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-01 DOI: 10.1016/j.hipert.2024.08.001

E. Achote , O.F. Arroyo Ripoll , M. Araujo-Castro

Pheochromocytoma is a rare neuroendocrine tumour that develops from chromaffin cells in the adrenal medulla and is characterised by the excessive production of catecholamines and their metabolites. Diagnostic confirmation is performed by detecting elevated levels of catecholamines and/or their metabolites in plasma or 24-h urine. In the case of moderate elevations of normetanephrine, the clonidine suppression test may be useful to differentiate between endogenous hypersecretion and false positive results. Once the biochemical diagnosis is performed, the tumour localisation is carried out using imaging techniques and sometimes with nuclear medicine imaging tests. Furthermore, in all patients with pheochromocytomas it is recommended to perform a genetic study to identify hereditary disorders that may be present in more than 30% of cases and to perform a cardiological evaluation to rule out the presence of cardiovascular involvement secondary to the catecholamine hypersecretion.

嗜铬细胞瘤是一种罕见的神经内分泌肿瘤，由肾上腺髓质中的绒毛膜细胞发展而来，其特点是过量产生儿茶酚胺及其代谢物。确诊方法是检测血浆或 24 小时尿液中儿茶酚胺和/或其代谢物水平的升高。在正常肾上腺素中度升高的情况下，氯硝安定抑制试验可能有助于区分内源性高分泌和假阳性结果。一旦进行了生化诊断，就需要使用成像技术进行肿瘤定位，有时还需要进行核医学成像检测。此外，建议对所有嗜铬细胞瘤患者进行遗传学检查，以确定30%以上病例可能存在的遗传性疾病，并进行心脏病学评估，以排除儿茶酚胺分泌过多继发心血管受累的可能性。

引用次数: 0

Peculiaridades del manejo de la hipertensión arterial en el anciano. Documento de consenso de la Sociedad Centroamericana y del Caribe de Hipertensión arterial [老年人动脉高血压管理的特殊性：中美洲和加勒比动脉高血压学会共识文件]。

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-01 DOI: 10.1016/j.hipert.2024.09.004

C. Sepulveda Gallardo , A.I. Barrientos , M.H. Koretzky , F. Wyss , O. Valdez Tiburcio , N. Báez Noyer , E. Sanchez , A. Gonzalez , W. Dones , P. López Contreras , M. Camafort

Arterial hypertension is one of the most prevalent diseases in the field of geriatrics and is also a risk factor for pathologies that frequently result in hospital admissions, such as heart failure and stroke. This article addresses both pharmacological and non-pharmacological diagnosis and treatment strategies, focusing on the role of frailty as a guiding principle in determining the most appropriate course of treatment, emphasizing patient-centred prescribing. Furthermore, the article reviews other frequent topics, such as polypharmacy and orthostatic hypotension. Moreover, a concise overview of the current evidence in geriatrics on ambulatory blood pressure monitoring and self-measurement of blood pressure will be provided. Furthermore, a brief summary of the underlying pathophysiology and current epidemiological trends is provided. This consensus is founded upon the initial premise that a comprehensive geriatric assessment should be conducted to ascertain whether a blood pressure reduction strategy could confer a net benefit for elderly patients while simultaneously avoiding an increase in the safety risks associated with these strategies and preventing a de-prescription due to ageism. This is particularly important given the significance of maintaining optimal blood pressure control to prevent related complications.

动脉高血压是老年医学领域最常见的疾病之一，也是导致心力衰竭和中风等常见病的危险因素。本文论述了药物和非药物诊断与治疗策略，重点阐述了虚弱在确定最合适治疗方案中的指导作用，强调以患者为中心的处方。此外，文章还回顾了其他经常出现的话题，如多药治疗和正性低血压。此外，文章还将简明扼要地概述当前老年医学中关于非卧床血压监测和自我测量血压的证据。此外，还简要概述了潜在的病理生理学和当前的流行病学趋势。这一共识建立在一个初步前提之上，即应进行全面的老年评估，以确定降压策略是否能为老年患者带来净效益，同时避免增加与这些策略相关的安全风险，并防止因年龄歧视而取消处方。鉴于保持最佳血压控制以预防相关并发症的重要性，这一点尤为重要。

{"title":"Peculiaridades del manejo de la hipertensión arterial en el anciano. Documento de consenso de la Sociedad Centroamericana y del Caribe de Hipertensión arterial","authors":"C. Sepulveda Gallardo , A.I. Barrientos , M.H. Koretzky , F. Wyss , O. Valdez Tiburcio , N. Báez Noyer , E. Sanchez , A. Gonzalez , W. Dones , P. López Contreras , M. Camafort","doi":"10.1016/j.hipert.2024.09.004","DOIUrl":"10.1016/j.hipert.2024.09.004","url":null,"abstract":"<div><div>Arterial hypertension is one of the most prevalent diseases in the field of geriatrics and is also a risk factor for pathologies that frequently result in hospital admissions, such as heart failure and stroke. This article addresses both pharmacological and non-pharmacological diagnosis and treatment strategies, focusing on the role of frailty as a guiding principle in determining the most appropriate course of treatment, emphasizing patient-centred prescribing. Furthermore, the article reviews other frequent topics, such as polypharmacy and orthostatic hypotension. Moreover, a concise overview of the current evidence in geriatrics on ambulatory blood pressure monitoring and self-measurement of blood pressure will be provided. Furthermore, a brief summary of the underlying pathophysiology and current epidemiological trends is provided. This consensus is founded upon the initial premise that a comprehensive geriatric assessment should be conducted to ascertain whether a blood pressure reduction strategy could confer a net benefit for elderly patients while simultaneously avoiding an increase in the safety risks associated with these strategies and preventing a de-prescription due to ageism. This is particularly important given the significance of maintaining optimal blood pressure control to prevent related complications.</div></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"42 1","pages":"Pages 36-42"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142584282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Detección de rigidez arterial en mujeres con antecedente reciente de preeclampsia [近期有先兆子痫病史的妇女的动脉僵化检测]。

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-01 DOI: 10.1016/j.hipert.2024.07.007

A.M. Ghelfi , M.N. Lassus , F.A. Passarino , R.F. Mamprin D’Andrea , L.N. Fierro , L.L. Velez , E.A. Hails , M.A. Paciocco , J.G. Kilstein , J.O. Galíndez

Introduction

Preeclampsia (PE) is a complication of hypertensive disorders of pregnancy, whose pathophysiology involves endothelial dysfunction. Early establishment of subclinical vascular lesions such as arterial stiffness (AS) could explain the development of cardiovascular disease later in life. AS can be assessed non-invasively using carotid-femoral pulse wave velocity (cf-PWV), aortic systolic blood pressure (ao-SBP) and augmentation index (IAx). We aim to determine cf-PWV, ao-SBP and AIx in women who recently underwent PE and compare it with a control group.

Materials and methods

Cross-sectional study, carried out from 2022 to 2023 in Argentina. Group 1: women who developed PE. Exclusion criteria: history of chronic hypertension, diabetes, autoimmune disease, chronic kidney disease, cardiovascular disease, PE in previous pregnancies; treatment with calcium antagonists during pregnancy; treatment with calcium antagonists, angiotensin-converting enzyme inhibitors or diuretics in the postpartum period. Group 2: healthy postpartum periods. PWV-cf, ao-SBP and IAx were measured in the first 72 hours postpartum using Aortic.

Results

Seventy-onewomen were included: Group 1 (n = 30); Group 2 (n = 41). Group 1 presented higher PWV-cf = 6.70 ± 0.68 vs. 5.41 ± 0.48 m/s (P<.0001); ao-SBP = 118.3 ± 9.6 vs. 101.2 ± 9.8 mmHg (P<.0001); and IAu = 22.7 ± 10.7 vs. 9.3 ± 11.9% (P<.0001). In Group 1 there were 25 of 30 women who presented AS parameters (OR = 8.50; 95% CI = 3.32-15.29; P<.0001).

Conclusion

Patients with a recent history of PE showed higher cf-PWV, ao-SBP and AIx values, compatible with AS.

导言：子痫前期（PE）是妊娠高血压疾病的一种并发症，其病理生理学涉及内皮功能障碍。动脉僵化（AS）等亚临床血管病变的早期形成可解释日后心血管疾病的发展。动脉僵化可通过颈动脉-股动脉脉搏波速度（cf-PWV）、主动脉收缩压（ao-SBP）和增强指数（IAx）进行无创评估。我们的目的是测定近期接受过 PE 的女性的 cf-PWV、ao-SBP 和 AIx，并将其与对照组进行比较：横断面研究，2022 年至 2023 年在阿根廷进行。排除标准：有慢性高血压、糖尿病、自身免疫性疾病、慢性肾脏疾病、心血管疾病病史，既往妊娠有 PE；妊娠期间接受过钙拮抗剂治疗；产后接受过钙拮抗剂、血管紧张素转换酶抑制剂或利尿剂治疗。第 2 组：产后健康。在产后 72 小时内使用主动脉测量仪测量脉搏波速度（PWV-cf）、ao-SBP 和 IAx：结果：共纳入 71 名妇女：结果：共纳入 71 名妇女：第一组（30 人）；第二组（41 人）。第 1 组的脉搏波速度-cf=6.70±0.68 对 5.41±0.48 m/s（PC）更高：近期有 PE 病史的患者显示出更高的 cf-PWV、ao-SBP 和 AIx 值，与 AS 相吻合。

{"title":"Detección de rigidez arterial en mujeres con antecedente reciente de preeclampsia","authors":"A.M. Ghelfi , M.N. Lassus , F.A. Passarino , R.F. Mamprin D’Andrea , L.N. Fierro , L.L. Velez , E.A. Hails , M.A. Paciocco , J.G. Kilstein , J.O. Galíndez","doi":"10.1016/j.hipert.2024.07.007","DOIUrl":"10.1016/j.hipert.2024.07.007","url":null,"abstract":"<div><h3>Introduction</h3><div>Preeclampsia (PE) is a complication of hypertensive disorders of pregnancy, whose pathophysiology involves endothelial dysfunction. Early establishment of subclinical vascular lesions such as arterial stiffness (AS) could explain the development of cardiovascular disease later in life. AS can be assessed non-invasively using carotid-femoral pulse wave velocity (cf-PWV), aortic systolic blood pressure (ao-SBP) and augmentation index (IAx). We aim to determine cf-PWV, ao-SBP and AIx in women who recently underwent PE and compare it with a control group.</div></div><div><h3>Materials and methods</h3><div>Cross-sectional study, carried out from 2022 to 2023 in Argentina. Group 1: women who developed PE. Exclusion criteria: history of chronic hypertension, diabetes, autoimmune disease, chronic kidney disease, cardiovascular disease, PE in previous pregnancies; treatment with calcium antagonists during pregnancy; treatment with calcium antagonists, angiotensin-converting enzyme inhibitors or diuretics in the postpartum period. Group 2: healthy postpartum periods. PWV-cf, ao-SBP and IAx were measured in the first 72hours postpartum using Aortic.</div></div><div><h3>Results</h3><div>Seventy-onewomen were included: Group 1 (n=30); Group 2 (n=41). Group 1 presented higher PWV-cf=6.70±0.68 vs. 5.41±0.48 m/s (<em>P</em><.0001); ao-SBP=118.3±9.6 vs. 101.2±9.8mmHg (<em>P</em><.0001); and IAu=22.7±10.7 vs. 9.3±11.9% (<em>P</em><.0001). In Group 1 there were 25 of 30 women who presented AS parameters (OR=8.50; 95% CI=3.32-15.29; <em>P</em><.0001).</div></div><div><h3>Conclusion</h3><div>Patients with a recent history of PE showed higher cf-PWV, ao-SBP and AIx values, compatible with AS.</div></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"42 1","pages":"Pages 3-12"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence, trends, and associated factors of isolated systolic, diastolic, and systolic–diastolic hypertension in Peru: A nine-year analysis of the Demographic and Family Health Survey 秘鲁孤立性收缩期、舒张期和收缩期-舒张期高血压的患病率、趋势和相关因素：人口与家庭健康调查九年分析》。

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-01 DOI: 10.1016/j.hipert.2024.10.001

V.J. Vera-Ponce , F.E. Zuzunaga-Montoya , L.E.M. Vásquez-Romero , J.A. Loayza-Castro , C.I. Gutierrez De Carrillo , E. Vigil-Ventura

Introduction

While HTN is widely seen as a primary threat to cardiovascular conditions worldwide, it is essential to recognize that not all HTN is identical.

Objective

To determine the prevalence, trend, and factors associated with each type of HTN: isolated systolic (ISH), isolated diastolic (IDH), and systolic–diastolic (SDH).

Methods

A secondary analysis of data from the Demographic and Family Health Survey from 2014 to 2022 was conducted. For the analysis of associated factors, a Poisson regression model with robust variance was implemented to calculate adjusted prevalence ratios (aPR) along with their 95% confidence intervals.

Results

The prevalence was 7.02%, 1.55%, and 3.28% for ISH, IDH, and SDH, respectively. ISH showed a decline in 2022, unlike the other two types, which seem to be on the rise. A statistically significant association was found in men and an increased risk with age for ISH and SDH, unlike IDH, where age acts as a protective factor. Additional factors identified include smoking and excessive alcohol consumption, while a high intake of fruits/vegetables offers a protective effect. Obesity and diabetes were associated with a higher risk, and significant variations by region and altitude, as well as among ethnic groups, were observed.

Conclusions

Significant differences in the prevalence of HTN subtypes have been found, underscoring the heterogeneity of this chronic condition, both in related factors and in trends over the years.

导言：虽然高血压被广泛视为全球心血管疾病的主要威胁，但必须认识到并非所有高血压都相同：确定每种类型高血压的患病率、趋势和相关因素：孤立收缩压（ISH）、孤立舒张压（IDH）和收缩-舒张压（SDH）：对 2014 年至 2022 年人口与家庭健康调查的数据进行了二次分析。为了分析相关因素，采用了具有稳健方差的泊松回归模型来计算调整患病率（aPR）及其 95% 的置信区间：ISH、IDH和SDH的患病率分别为7.02%、1.55%和3.28%。ISH在2022年呈下降趋势，而其他两种类型似乎呈上升趋势。在统计学上发现，ISH 和 SDH 与男性有明显关联，随着年龄的增长，患病风险也会增加，而 IDH 则不同，年龄是一个保护因素。发现的其他因素包括吸烟和过度饮酒，而摄入大量水果/蔬菜则具有保护作用。肥胖和糖尿病与较高的风险有关，不同地区、不同海拔以及不同种族群体之间存在显著差异：结论：研究发现，高血压亚型的患病率存在显著差异，这凸显了这种慢性疾病在相关因素和多年趋势方面的异质性。

{"title":"Prevalence, trends, and associated factors of isolated systolic, diastolic, and systolic–diastolic hypertension in Peru: A nine-year analysis of the Demographic and Family Health Survey","authors":"V.J. Vera-Ponce , F.E. Zuzunaga-Montoya , L.E.M. Vásquez-Romero , J.A. Loayza-Castro , C.I. Gutierrez De Carrillo , E. Vigil-Ventura","doi":"10.1016/j.hipert.2024.10.001","DOIUrl":"10.1016/j.hipert.2024.10.001","url":null,"abstract":"<div><h3>Introduction</h3><div>While HTN is widely seen as a primary threat to cardiovascular conditions worldwide, it is essential to recognize that not all HTN is identical.</div></div><div><h3>Objective</h3><div>To determine the prevalence, trend, and factors associated with each type of HTN: isolated systolic (ISH), isolated diastolic (IDH), and systolic–diastolic (SDH).</div></div><div><h3>Methods</h3><div>A secondary analysis of data from the Demographic and Family Health Survey from 2014 to 2022 was conducted. For the analysis of associated factors, a Poisson regression model with robust variance was implemented to calculate adjusted prevalence ratios (aPR) along with their 95% confidence intervals.</div></div><div><h3>Results</h3><div>The prevalence was 7.02%, 1.55%, and 3.28% for ISH, IDH, and SDH, respectively. ISH showed a decline in 2022, unlike the other two types, which seem to be on the rise. A statistically significant association was found in men and an increased risk with age for ISH and SDH, unlike IDH, where age acts as a protective factor. Additional factors identified include smoking and excessive alcohol consumption, while a high intake of fruits/vegetables offers a protective effect. Obesity and diabetes were associated with a higher risk, and significant variations by region and altitude, as well as among ethnic groups, were observed.</div></div><div><h3>Conclusions</h3><div>Significant differences in the prevalence of HTN subtypes have been found, underscoring the heterogeneity of this chronic condition, both in related factors and in trends over the years.</div></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"42 1","pages":"Pages 18-28"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Trastornos hipertensivos de novo en el posparto: consideraciones sobre su diagnóstico, factores de riesgo y posibles estrategias de intervención [产后新发高血压疾病：关于诊断、风险因素和潜在干预策略的考虑]。

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-01 DOI: 10.1016/j.hipert.2024.09.001

P.G. Irusta

Postpartum de novo arterial hypertension (PPDNAH) is defined as blood pressure ≥140/90 mmHg, without a history of hypertension during pregnancy or delivery. Its prevalence ranges from 0.3% to 27.5% of all pregnancies. Late-onset postpartum preeclampsia (LOPPP) and late-onset postpartum eclampsia (LOPPE) typically occur between 48 hours and 6 weeks postpartum, although recent studies demonstrate the possibility of developing these disorders up to 12 months postpartum.

While sharing risk factors with pregnancy-related disorders, they differ in some aspects such as primigravida status. Regarding prognosis, an increase in severe maternal morbidity has been observed compared to hypertensive disorders of pregnancy.

This group of pathologies is often underdiagnosed, even in high-risk patients, making early identification along with strict blood pressure monitoring essential.

产后新发动脉高血压（PPDNAH）的定义是血压≥140/90mmHg，且在怀孕或分娩期间没有高血压病史。其发病率占所有妊娠的 0.3% 至 27.5%。晚发性产后子痫前期（LOPPP）和晚发性产后子痫（LOPPE）通常发生在产后 48 小时至 6 周之间，但最近的研究表明，这些疾病有可能在产后 12 个月内发生。虽然与妊娠相关疾病具有相同的风险因素，但它们在某些方面（如初产妇身份）有所不同。在预后方面，与妊娠期高血压疾病相比，产妇的严重发病率有所上升。这类病症往往诊断不足，甚至在高危患者中也是如此，因此必须及早发现并进行严格的血压监测。

引用次数: 0

Metastatic pheochromocytoma: An unusual case and its multidisciplinary management 转移性嗜铬细胞瘤：一个不寻常的病例及其多学科治疗。

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-01 DOI: 10.1016/j.hipert.2024.09.002

J.M. Ruiz-Cánovas , E.A. Achote-Rea , T. Alonso-Gordoa , A. Martínez-Lorca , M. Araujo-Castro

We describe the case of an 80-year-old man with sporadic right pheochromocytoma who developed metastatic disease six years after initial diagnosis. Despite adequate blood pressure control and initial biochemical cure criteria after surgery, elevated chromogranin A levels were detected during routine screening, which anticipated elevated 24-h urine metanephrines. Subsequent imaging tests revealed metastatic lesions in the lungs, liver, prostate and lymph nodes. The patient underwent systemic treatment with [131I] MIBG, which resulted in a decrease in chromogranin A levels, achieving radiological and clinical stability. This case highlights the importance of long-term follow-up and biochemical monitoring for early detection of tumor recurrence in patients with pheochromocytoma, emphasizing the need for individualized treatment strategies and interdisciplinary care.

我们描述了一例患有散发性右侧嗜铬细胞瘤的 80 岁男性病例，他在初次确诊六年后出现了转移性疾病。尽管手术后血压得到了充分控制，并达到了最初的生化治愈标准，但在常规筛查中发现嗜铬粒蛋白 A 水平升高，这预示着 24 小时尿中的甲肾上腺素升高。随后的影像学检查发现肺部、肝脏、前列腺和淋巴结有转移病灶。患者接受了[131I] MIBG的全身治疗，结果嗜铬粒蛋白A水平有所下降，达到了放射学和临床稳定。本病例强调了长期随访和生化监测对于早期发现嗜铬细胞瘤患者肿瘤复发的重要性，强调了个体化治疗策略和跨学科护理的必要性。

引用次数: 0

The reference arm – The eternal doubt 参考臂-永恒的怀疑。

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular

Pub Date : 2025-01-01 DOI: 10.1016/j.hipert.2024.12.003

N. Soldevila Bacardit, E. Vinyoles Bargalló

引用次数: 0

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Hipertension y Riesgo Vascular

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀